bioRxivImmunology
Streptococcus pneumoniae serotypes carried by young children and their association with Acute Otitis Media during the period 2016 - 2019.
E. Ekinci, S. Desmet, L. Van Heirstraeten, C. Mertens, I. Wouters, P. Beutels, J. Verhaegen, S. Malhotra-Kumar, H. Theeten, T. Npcarriage Study Group
Abstract
BackgroundStreptococcus pneumoniae (Sp) is a major cause of acute otitis media (AOM). Pneumococcal conjugate vaccine (PCV) programs have altered pneumococcal serotype epidemiology in disease and carriage. To establish the clinical picture of AOM in young children exposed to the PCV program in Belgium and the Sp strains they carry, a cross-sectional study started in 2016. Material/methodsIn three collection periods from February 2016 to May 2018, nasopharyngeal swabs and background characteristics were collected from children aged 6-30 months either presenting at their physician with AOM (AOM-group) or healthy and attending day care (DCC-group). Sp was detected, quantified, and characterized using both conventional culture and qPCR. Clinical signs of AOM episodes and treatment were registered by the physicians. ResultsAmong 3264 collected samples, overall pneumococcal carriage and density were similar in AOM (79.2% and 0.50 x106 copies/l) and DCC (77.5% and 0.42 x106 copies/l). Non-vaccine serotypes were most frequent: 23B (AOM: 12.3%; DCC: 17.4%), 11A (AOM: 7.5%; DCC: 7.4%) and 15B (AOM: 7.5%; DCC: 7.1%). Serotypes 3, 6C, 7B, 9N, 12F, 17F and 29 were more frequent in AOM than in DCC, whereas 23A and 23B frequencies were lower. Antibiotic susceptibility of Sp strains was similar in both groups . No predictors of AOM severity were identified, and 77.3% received an antibiotic prescription. ConclusionYoung children with AOM did not carry Sp more frequently or at higher load than healthy children in day care, but some ST were more frequent in AOM and are not included in the currently used vaccines.
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Streptococcus pneumoniae vaccine serotype persistence following 13-valent pneumococcal conjugate vaccine introduction in Mongolia: investigating changes in epidemiology, immunology and virulence
Paige Skoko, Sam Manna, … Catherine Satzke·bioRxiv·Sep 23, 2025
- Therapeutic immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density, shedding, and middle ear infection in mice
J. Manning, S. Manna, … C. Satzke·bioRxiv·Apr 5, 2023
- Comparison of early effects of PCV7, PCV10 and PCV13 on S. pneumoniae (SP) nasopharyngeal carriage in a population based study; the Palestinian-Israeli Collaborative Research (PICR)
R. Abu Seir, K. Azmi, … G. Regev-Yochay·bioRxiv·Sep 7, 2018
- Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data
Chrispin Chaguza, Ellen Heinsbroek, … Stephen D. Bentley·Clinical Infectious DiseasesPeer-reviewed·May 15, 2019
- Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci
T. Azarian, P. Mitchell, … W. P. Hanage·bioRxiv·Jun 27, 2018
- Evidence of virulence and antimicrobial resistance in Streptococcus pneumoniae serotype 16F lineages
Jolynne Mokaya, Kate C. Mellor, … Felix Sizwe Dube·bioRxiv·Aug 25, 2023